[EFFECT] Avalo Therapeutics, Inc. SEC Filing Filing Impact (Neutral) Filing Sentiment (Neutral) Form Type EFFECT Rhea-AI Filing Summary Analyzing... 01/21/2026 - 12:15 AM ⛶ Fullscreen UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: January 20, 2026 9:00 A.M. Form: S-3 CIK: 0001534120 Company Name: Avalo Therapeutics, Inc. File Number: 333-292614 Source: View Original Filing on SEC EDGAR
